Chief Executive of Vectura Group to step down Chief Executive of Vectura Group to step down Chris Blackwell will leave the company on 30 June 2015 Nabriva Therapeutics strengthens board and management team Nabriva Therapeutics strengthens board and management team Charles Rowland and Dr Steven Gelone join the company Sygnature Discovery makes three key appointments Sygnature Discovery makes three key appointments Tim Schulz-Utermoehl will lead the new DMPK department Francesco Sinigaglia becomes Chairman at Eyevensys Francesco Sinigaglia becomes Chairman at Eyevensys Raffy Kazandjian is Chief Executive at the French ophthalmic company Crown Bioscience strengthens pre-clinical leadership team Crown Bioscience strengthens pre-clinical leadership team Hires Laurie Heilmann as Senior Vice President Global Strategy, Marketing Business Development Heptares scientists receive 2015 Malcolm Campbell Memorial Prize Heptares scientists receive 2015 Malcolm Campbell Memorial Prize In recognition of their contribution to GPCR drug discovery Mark Sawicki joins Cryoport as Chief Commercial Officer Mark Sawicki joins Cryoport as Chief Commercial Officer Will lead the sales and marketing team at the cryogenic logistics solutions company Medivir makes changes to management team Medivir makes changes to management team To create a smaller and more effective team with fewer functions ABPI appoints Dr Virginia Acha as Research Medical and Innovation Director ABPI appoints Dr Virginia Acha as Research Medical and Innovation Director She takes up the position at the beginning of March Cornelius Group Board reorganises for growth Cornelius Group Board reorganises for growth Darren Spiby takes responsibility for the overall UK and international business Domino makes three promotions Domino makes three promotions Three members of the coding and marking company take up more senior sales roles Promethera Biosciences sees departure of CEO Eric Halioua Promethera Biosciences sees departure of CEO Eric Halioua The recruitment process to find his successor is underway XenoGesis appoints Director of External Projects XenoGesis appoints Director of External Projects Graham Trevitt joins the Nottingham, UK-based contract research organisation Paul Thomas joins Aegate as Regional Business Development Manager UK & Ireland Paul Thomas joins Aegate as Regional Business Development Manager UK & Ireland Formerly Head of Sales at Novo Nordisk New Vice-Chair appointed to Commission on Human Medicines New Vice-Chair appointed to Commission on Human Medicines Dr Angela Thomas replaces Professor Ian Weller Mission Therapeutics appoints Anker Lundemose as Chief Executive Mission Therapeutics appoints Anker Lundemose as Chief Executive UK company is in the transition stage from discovery to development of treatments for cancer